Protein Digestion After Bariatric Surgery in Older Adults
NCT ID: NCT06076187
Last Updated: 2025-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
72 participants
OBSERVATIONAL
2023-05-15
2026-11-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Does protein digestibility decrease after Roux-en-Y-Gastric Bypass? Does protein digestibility decrease after Sleeve Gastrectomy surgery? Does protein digestibility effect the ability to meet protein requirements?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Protein Requirements After Bariatric Surgery
NCT06853652
Gastro-Intestinal Digestion and Physiology After Bariatric Surgery
NCT07286968
Controlled Trial Evaluating the Efficacy of Protein Supplementation in the Short Term After Bariatric Surgery
NCT02712086
Protein Supplementation Post Bariatric Surgery
NCT02951663
Effect of Protein Supplementation on Fat Free Mass Preservation After Bariatric Surgery
NCT05570474
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1: Patients over 65 years of age who had undergone Roux-en-Y bariatric surgery
Group 1: Patients over 65 years of age who had undergone Roux-en-Y bariatric surgery
Dual isotope protein digestibility method
Dual isotope method
Group 2: Patients over 65 years of age who had undergone sleeve gastrectomy surgery
Group 2: Patients over 65 years of age who had undergone sleeve gastrectomy surgery
Dual isotope protein digestibility method
Dual isotope method
Group 3: Patients over 65 years of age without previous bariatric surgery
Group 3: Patients over 65 years of age without previous bariatric surgery
Dual isotope protein digestibility method
Dual isotope method
Group 4: Patients younger than 65 years of age who had undergone Roux-en-Y bariatric surgery
Group 4: Patients younger than 65 years of age who had undergone Roux-en-Y bariatric surgery
Dual isotope protein digestibility method
Dual isotope method
Group 5: Patients younger than 65 years of age who had undergone Sleeve Gastrectomy
Group 5: Patients younger than 65 years of age who had undergone Sleeve Gastrectomy
Dual isotope protein digestibility method
Dual isotope method
Group 6: Patients younger then 65 years of age without previous bariatric surgery
Group 6: Patients younger then 65 years of age without previous bariatric surgery
Dual isotope protein digestibility method
Dual isotope method
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dual isotope protein digestibility method
Dual isotope method
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Group 1,2,3: Age 65 years or older
* Group 4,5,6: Age 18 to 65 years
* Group 1,2,4,5: Previous bariatric surgery for obesity 1 - 10 years ago
* Group 3,6: No previous weight loss surgery
Exclusion Criteria
* Advanced organ failure, including chronic kidney disease Stage 5, liver cirrhosis Stage 3, intestinal failure, heart failure stage D, or chronic obstructive pulmonary disease stage 4.
* Immobility
* Neuromuscular degenerative conditions
* Gastrointestinal conditions including coeliac disease, Crohn's disease, previous resection of the small intestine, gastroparesis
* Unable to follow the procedures of the studies due to cognitive impairment such as diagnosed dementia.
* Allergy/intolerance to milk, or soy or spirulina
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitaire Ziekenhuizen KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitaire Ziekenhuizen KU Leuven
Leuven, Flemish Brabant, Belgium
UZLeuven
Leuven, Vlaams Brabant, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Bart Van der Schueren
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S67116
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.